
### [MONDO:0019954](http://purl.obolibrary.org/obo/MONDO_0019954)
**Label:** pancreatic neuroendocrine tumor

**Subclasses:** [MONDO:0006976](http://purl.obolibrary.org/obo/MONDO_0006976) (somatostatinoma), [MONDO:0019955](http://purl.obolibrary.org/obo/MONDO_0019955) (GRFoma), [MONDO:0005048](http://purl.obolibrary.org/obo/MONDO_0005048) (insulinoma (disease)), [MONDO:0019610](http://purl.obolibrary.org/obo/MONDO_0019610) (Zollinger-Ellison syndrome), [MONDO:0019960](http://purl.obolibrary.org/obo/MONDO_0019960) (VIPoma), [MONDO:0019959](http://purl.obolibrary.org/obo/MONDO_0019959) (glucagonoma), [MONDO:0019957](http://purl.obolibrary.org/obo/MONDO_0019957) (PPoma), 

**Corr. equiv. classes:** [Orphanet:97283](http://www.orpha.net/ORDO/Orphanet_97283), [Orphanet:97261](http://www.orpha.net/ORDO/Orphanet_97261), [Orphanet:97282](http://www.orpha.net/ORDO/Orphanet_97282), [Orphanet:97280](http://www.orpha.net/ORDO/Orphanet_97280), [Orphanet:97279](http://www.orpha.net/ORDO/Orphanet_97279), [Orphanet:913](http://www.orpha.net/ORDO/Orphanet_913), [Orphanet:97278](http://www.orpha.net/ORDO/Orphanet_97278), 

**Class expressions from DL-Learner:**

- [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) and [HP:0200013](http://purl.obolibrary.org/obo/HP_0200013) (Neoplasm of fatty tissue) 71.43%
- [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) and [HP:0100733](http://purl.obolibrary.org/obo/HP_0100733) (Neoplasm of the parathyroid gland) 71.43%
- [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) and [HP:0100641](http://purl.obolibrary.org/obo/HP_0100641) (Neoplasm of the adrenal cortex) 71.43%
- [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) and [HP:0100631](http://purl.obolibrary.org/obo/HP_0100631) (Neoplasm of the adrenal gland) 71.43%
- [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) and [HP:0040277](http://purl.obolibrary.org/obo/HP_0040277) (Neoplasm of the pituitary gland) 71.43%
- [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) and [HP:0030338](http://purl.obolibrary.org/obo/HP_0030338) (Abnormal circulating gonadotropin level) 71.43%
- [HP:0012031](http://purl.obolibrary.org/obo/HP_0012031) (Lipomatous tumor) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 71.43%
- [HP:0011767](http://purl.obolibrary.org/obo/HP_0011767) (Abnormality of the parathyroid physiology) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 71.43%
- [HP:0011766](http://purl.obolibrary.org/obo/HP_0011766) (Abnormality of the parathyroid morphology) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 71.43%
- [HP:0011750](http://purl.obolibrary.org/obo/HP_0011750) (Neoplasm of the anterior pituitary) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 71.43%
- [HP:0011732](http://purl.obolibrary.org/obo/HP_0011732) (Abnormality of adrenal morphology) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 71.43%
- [HP:0010514](http://purl.obolibrary.org/obo/HP_0010514) (Hyperpituitarism) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 71.43%
- [HP:0009124](http://purl.obolibrary.org/obo/HP_0009124) (Abnormality of adipose tissue) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 71.43%
- [HP:0008256](http://purl.obolibrary.org/obo/HP_0008256) (Adrenocortical adenoma) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 71.43%
- [HP:0008200](http://purl.obolibrary.org/obo/HP_0008200) (Primary hyperparathyroidism) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 71.43%


